BuzzSparks.org

Novo Ventures


Novo A/S is a Danish private limited liability company wholly owned by the Novo Nordisk Foundation, and the holding company of the Novo Group and as such the majority shareholder in the publicly listed companies Novo Nordisk A/S and Novozymes A/S. ...

Homepage:

DK-2880 Krogshoejvej 41

Bagsvaerd
Bagsvaerd
DNK

Phone: +45 88 24 88 24

Updated on Jun 1, 2009
Novo Ventures at CrunchBase
Sten Scheibye Chairman, Board of Directors
Henrik Gürtler CEO
Thorkil K. Christensen CFO
Ulf J. Johansson Chairman of the board
Göran Ando Director, Board of Directors
Jeppe Christiansen Director, Board of Directors
Per Wold-Olsen Director, Board of Directors
Ulrik Spork Managing Partner, Large Investments
Birgitta Ravn-Holm Executive Assistant, Executive Office
Scott A. Beardsley Partner
Kim Dueholm Partner
Martin Edwards Senior Partner
Stephan Christgau Investment Director, Seeds
Heather Ludvigsen Venture Auditor
Heath Lukatch Partner
Lone Penby Venture Coordinator
Nanna Lüneborg Principal
Dorte Barlebo Madsen HR Director
Søren Møller Managing Investment Director
Henrijette Ricther Investment Director
Jørgen Rønnow General Counsel
Michael Shalmi Senior Partner
Peter Bisgaard Partner & Investment Manager
Jørgen Boe Director, Board of Directors
Steen Riisgaard Director, Board of Directors
Søren Carlsen Managing Partner
Inge Hoffmann Personal Assistant, Executive Office
Tiba Aynechi Principal
Johan Brønnum-Schou Investment Director
Thomas Dyrberg Senior Partner
Cory Freedland Principal
Hanne Falk Estrup Administrative Coordinator, Finance
Morten Beck Jørgensen Senior Investment Director
Peter Moldt Partner
Nicole Zilveti Office Manager
Max Løwe Controller
Berit Mikkelsen Seed Controller
Jack B. Nielsen Partner
Dorrit T. Ryd IT manager
Susanne Schou Administrative Coordinator
Bobby Soni Principal
Past

September, 2013

Novo Ventures invested $45.9M in Otonomy as a Series C round

March, 2013

Novo Ventures invested $48M in Nevro as a Series C round

January, 2013

Novo Ventures invested $19.5M in Ceterix Orthopaedics as a Series B round

December, 2012

Novo Ventures invested $20M in Flexion Therapeutics as a Series B round

October, 2012

Novo Ventures invested $16M in Thesan Pharmaceuticals as a Series A round

April, 2012

Novo Ventures invested $38M in Alder Biopharmaceuticals as a Series D round

January, 2012

Novo Ventures invested $30M in Elevation Pharmaceuticals as a Series B round

October, 2011

Novo Ventures invested $40M in Imagen Biotech as a Series A round

May, 2011

Novo Ventures invested $19.3M in Delenex Therapeutics as a Series A round

April, 2011

Novo Ventures invested $20.3M in f-star Biotech as unattributed round

August, 2010

Novo Ventures invested $38.5M in Otonomy as a Series B round

June, 2010

Novo Ventures invested $29M in Foldrx Pharmaceuticals as unattributed round

May, 2010

Novo Ventures invested $12.2M in Funxional Therapeutics as a Series B round

Novo Ventures invested $43M in NeuroTherapeutics Pharma as a Series B round

January, 2010

Novo Ventures invested $30M in Neomend as a Series D round

Novo Ventures invested $24M in Tarsa Therapeutics as a Series A round

November, 2009

Novo Ventures invested $8.6M in Metabolex as unattributed round

August, 2009

Novo Ventures invested $29M in Gloucester Pharmaceuticals as a Series D round

June, 2009

Novo Ventures invested $23M in MediQuest Therapeutics as a Series B round

Novo Ventures invested $8M in Alios BioPharma as a Series A round

February, 2009

Novo Ventures invested $24M in Alios BioPharma as a Series A round

January, 2009

Novo Ventures invested $29M in Synosia Therapeutics as a Series B round

April, 2007

Novo Ventures invested $32M in Metabolex as a Series D round

January, 2006

Novo Ventures invested $27M in ProteinSimple as a Series B round